Get the Stockscreener App
6.41
1.75%
0.11
After Hours:
6.42
0.010
+0.16%
Novavax Inc Stock (NVAX) Forecast
The Novavax Inc (NVAX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $51.53, representing a +703.96% increase from the current price of $6.41. The highest analyst price target is $64.32, and the lowest is $38.75.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVAX Price Target
Average 184.38
(+2,776% Upside)
Is Novavax Inc (NVAX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.25 | Neutral |
| STOCH(9,6) | 13.31 | Buy |
| STOCHRSI(14) | 18.60 | Buy |
| MACD(12,26) | -0.0261 | Sell |
| ADX(14) | 18.31 | Neutral |
| William %R | -98.03 | Buy |
| CCI(14) | -236.91 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.006
Sell
|
6.8781
Sell
|
| MA20 |
7.101
Sell
|
6.9457
Sell
|
| MA50 |
6.7062
Sell
|
6.9687
Sell
|
| MA100 |
7.2571
Sell
|
7.3679
Sell
|
| MA200 |
8.7136
Sell
|
8.027
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NVAX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on NVAX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.25 indicates that NVAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 13.31 indicates that NVAX is oversold. This indicates that NVAX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 18.6 indicates that NVAX is oversold. This suggests that NVAX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.31 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -236.91 indicates that NVAX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NVAX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Novavax Inc financial reports and earnings history, Novavax Inc (NVAX) stock could reach $4.1836 by 2030, $5.3488 by 2040 and $83.18 by 2050. See the projected annual prices until 2050 of the Novavax Inc stock below:
- Novavax Inc (NVAX) is expected to reach an average price of $2.8087 in 2035, with a high prediction of $4.7215 and a low estimate of $2.5387. This indicates an $-56.18% rise from the last recorded price of $6.41.
- Novavax Inc (NVAX) stock is projected to chart a bullish course in 2040, with an average price target of $3.3442, representing an $-47.83% surge from its current level. The forecast ranges from a conservative $2.508 to a sky-high $5.3488.
- Our analysts predict Novavax Inc (NVAX) to jump 60.60% by 2045, soaring from $10.22 to an average price of $10.29, potentially reaching $27.34. While $10.22 is the low estimate, the potential upside is significant.
- Novavax Inc (NVAX) stock is expected to climb by 2050, reaching an average of $74.50, a $1,062% jump from its current level. However, a wide range of estimates exists, with high and low targets of $83.18 and $58.01, respectively, highlighting the market's uncertainty.
Novavax Inc Stock (NVAX) Year by Year Forecast
Novavax Inc Stock (NVAX) Price Forecast for 2025
Novavax Inc Stock (NVAX) is expected to reach an average price of $94.77 in 2025, with a high prediction of $187.67 and a low estimate of $1.8639. This indicates an +1,378% rise from the last recorded price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $63.17 | $38.75 | $64.32 | +885.42% |
| August, 2025 | $92.62 | $57.56 | $110.03 | +1,345% |
| September, 2025 | $168.56 | $93.52 | $187.67 | +2,530% |
| October, 2025 | $91.21 | $84.94 | $179.97 | +1,323% |
| November, 2025 | $106.64 | $81.50 | $124.82 | +1,564% |
| December, 2025 | $79.00 | $76.79 | $120.21 | +1,133% |
Novavax Inc Stock (NVAX) Price Forecast for 2026
The predicted value for Novavax Inc (NVAX) in 2026 is set at an average of $202.45. Estimates vary from a peak of $330.00 to a trough of $74.89, indicating an +3,058% surge from the present price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $123.99 | $74.89 | $130.30 | +1,834% |
| February, 2026 | $123.11 | $104.42 | $148.81 | +1,821% |
| March, 2026 | $125.75 | $105.39 | $135.89 | +1,862% |
| April, 2026 | $276.21 | $119.58 | $330.00 | +4,209% |
| May, 2026 | $226.58 | $145.72 | $275.48 | +3,435% |
| June, 2026 | $178.08 | $157.42 | $239.81 | +2,678% |
| July, 2026 | $130.04 | $115.47 | $262.02 | +1,929% |
| August, 2026 | $208.04 | $126.93 | $212.86 | +3,145% |
| September, 2026 | $186.96 | $167.16 | $227.86 | +2,817% |
| October, 2026 | $188.25 | $170.38 | $245.02 | +2,837% |
| November, 2026 | $236.92 | $190.37 | $258.37 | +3,596% |
| December, 2026 | $205.44 | $196.39 | $276.18 | +3,105% |
Novavax Inc Stock (NVAX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Novavax Inc (NVAX) is $134.13, with a high forecast of $234.91 and a low forecast of $33.35. This indicates an +1,993% increase from the last price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $132.98 | $119.75 | $190.79 | +1,975% |
| February, 2027 | $190.74 | $128.48 | $199.88 | +2,876% |
| March, 2027 | $215.73 | $136.66 | $227.41 | +3,266% |
| April, 2027 | $109.24 | $99.52 | $234.91 | +1,604% |
| May, 2027 | $87.76 | $64.80 | $105.95 | +1,269% |
| June, 2027 | $70.16 | $67.93 | $99.82 | +994.47% |
| July, 2027 | $72.09 | $64.26 | $84.04 | +1,025% |
| August, 2027 | $45.10 | $44.48 | $76.10 | +603.59% |
| September, 2027 | $53.75 | $39.79 | $61.68 | +738.52% |
| October, 2027 | $38.71 | $33.35 | $55.95 | +503.84% |
| November, 2027 | $74.59 | $37.85 | $75.24 | +1,064% |
| December, 2027 | $39.95 | $36.64 | $73.81 | +523.28% |
Novavax Inc Stock (NVAX) Price Forecast for 2028
In 2028, Novavax Inc (NVAX) is projected to reach an average price of $23.33, with a high projection of $42.50 and a low estimate of $4.1541. This indicates an +263.95% rise from the last price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $28.88 | $28.81 | $42.50 | +350.54% |
| February, 2028 | $16.70 | $16.35 | $31.86 | +160.48% |
| March, 2028 | $20.78 | $14.50 | $23.15 | +224.12% |
| April, 2028 | $15.05 | $14.83 | $24.17 | +134.84% |
| May, 2028 | $8.182 | $7.8802 | $17.07 | +27.64% |
| June, 2028 | $10.08 | $7.2738 | $12.23 | +57.24% |
| July, 2028 | $8.4164 | $8.0164 | $11.18 | +31.30% |
| August, 2028 | $5.0655 | $4.7955 | $8.8183 | -20.98% |
| September, 2028 | $7.0127 | $4.1541 | $7.5027 | +9.40% |
| October, 2028 | $6.2699 | $5.4499 | $8.2363 | -2.19% |
| November, 2028 | $6.1889 | $5.2053 | $9.9217 | -3.45% |
| December, 2028 | $6.0061 | $5.1361 | $7.0975 | -6.30% |
Novavax Inc Stock (NVAX) Price Forecast for 2029
The 2029 price forecast for Novavax Inc Stock (NVAX) is $5.5239 on average, with a high prediction of $8.8977 and a low estimate of $2.15. This represents an -13.82% decrease from the previous price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.8651 | $5.4779 | $8.7597 | +22.70% |
| February, 2029 | $6.6423 | $5.4337 | $8.1923 | +3.62% |
| March, 2029 | $6.3095 | $5.8995 | $8.8977 | -1.57% |
| April, 2029 | $5.6567 | $5.3253 | $6.7549 | -11.75% |
| May, 2029 | $4.8557 | $4.5657 | $6.1057 | -24.25% |
| June, 2029 | $4.1929 | $3.9193 | $5.1275 | -34.59% |
| July, 2029 | $3.4302 | $3.4302 | $4.6747 | -46.49% |
| August, 2029 | $2.6392 | $2.5892 | $3.972 | -58.83% |
| September, 2029 | $3.9364 | $2.1752 | $4.1064 | -38.59% |
| October, 2029 | $3.3554 | $2.8782 | $4.6982 | -47.65% |
| November, 2029 | $2.6326 | $2.4726 | $3.6072 | -58.93% |
| December, 2029 | $2.81 | $2.15 | $5.88 | -56.16% |
Novavax Inc Stock (NVAX) Price Forecast for 2030
Novavax Inc Stock (NVAX) is expected to reach an average price of $7.107 in 2030, with a high forecast of $14.15 and a low forecast of $0.0683. This signifies an +10.87% surge from the last price of $6.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.313 | $0.9481 | $4.1836 | -79.52% |
| February, 2030 | $1.3024 | $1.1524 | $3.4552 | -79.68% |
| March, 2030 | $0.6559 | $0.3932 | $1.216 | -89.77% |
| April, 2030 | $2.2613 | $0.3589 | $4.4877 | -64.72% |
| May, 2030 | $1.4393 | $1.3593 | $4.0021 | -77.55% |
| June, 2030 | $0.8237 | $0.5437 | $1.5129 | -87.15% |
| July, 2030 | $0.1317 | $0.0683 | $1.2345 | -97.94% |
| August, 2030 | $0.4242 | $0.0953 | $2.0389 | -93.38% |
| September, 2030 | $0.3556 | $0.2777 | $1.1406 | -94.45% |
| October, 2030 | $4.0786 | $0.076 | $6.3678 | -36.37% |
| November, 2030 | $4.753 | $3.7622 | $14.15 | -25.85% |
| December, 2030 | $11.80 | $3.2266 | $12.03 | +84.05% |
1.86%
1.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):